EPCR expression marks UM171-expanded CD34+ cord blood stem cells I Fares, J Chagraoui, B Lehnertz, T MacRae, N Mayotte, E Tomellini, ... Blood, The Journal of the American Society of Hematology 129 (25), 3344-3351, 2017 | 189 | 2017 |
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer L Aubert, N Nandagopal, Z Steinhart, G Lavoie, S Nourreddine, J Berman, ... Nature communications 11 (1), 3701, 2020 | 151 | 2020 |
The receptor tyrosine kinase AXL is required at multiple steps of the metastatic cascade during HER2-positive breast cancer progression MA Goyette, S Duhamel, L Aubert, A Pelletier, P Savage, MP Thibault, ... Cell reports 23 (5), 1476-1490, 2018 | 141 | 2018 |
Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules AL Lainé, A Clavreul, A Rousseau, C Tétaud, A Vessieres, E Garcion, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (8), 1667-1677, 2014 | 42 | 2014 |
NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib L Aubert, M Guilbert, C Corbet, E Génot, E Adriaenssens, T Chassat, ... Oncotarget 6 (12), 9807, 2015 | 37 | 2015 |
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities S Cardin, M Bilodeau, M Roussy, L Aubert, T Milan, L Jouan, A Rouette, ... Blood advances 3 (21), 3307-3321, 2019 | 30 | 2019 |
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2 R Lévêque, C Corbet, L Aubert, M Guilbert, C Lagadec, E Adriaenssens, ... Cancer Letters 449, 196-206, 2019 | 28 | 2019 |
NF45 and NF90 regulate mitotic gene expression by competing with Staufen-mediated mRNA decay S Nourreddine, G Lavoie, J Paradis, KB El Kadhi, A Meant, L Aubert, ... Cell Reports 31 (7), 2020 | 22 | 2020 |
Extracellular signal-regulated kinases 1 and 2 phosphorylate Gab2 to promote a negative-feedback loop that attenuates phosphoinositide 3-kinase/Akt signaling X Zhang, G Lavoie, A Méant, L Aubert, M Cargnello, A Haman, T Hoang, ... Molecular and Cellular Biology 37 (7), e00357-16, 2017 | 21 | 2017 |
Proteomic analysis reveals a role for RSK in p120-catenin phosphorylation and melanoma cell-cell adhesion A Méant, B Gao, G Lavoie, S Nourreddine, F Jung, L Aubert, ... Molecular & Cellular Proteomics 19 (1), 50-64, 2020 | 19 | 2020 |
Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells S Trouvilliez, J Cicero, R Lévêque, L Aubert, C Corbet, A Van Outryve, ... Journal of experimental & clinical cancer research 41 (1), 110, 2022 | 13 | 2022 |
The receptor tyrosine kinase AXL is required at multiple steps of the metastatic Cascade during HER2-positive breast Cancer progression. Cell Rep. 2018; 23: 1476–90 MA Goyette, S Duhamel, L Aubert, A Pelletier, P Savage, MP Thibault, ... Epub 2018/05/03. doi: 10.1016/j. celrep. 2018.04. 019. PubMed PMID: 29719259, 0 | 12 | |
Targeting copper metabolism to defeat KRAS-driven colorectal cancer L Aubert, N Nandagopal, PP Roux Molecular & Cellular Oncology 7 (6), 1822123, 2020 | 5 | 2020 |
CBFA2T3::GLIS2 Pediatric Acute Megakaryoblastic Leukemia is Sensitive to BCL-XL Inhibition by Navitoclax and DT2216 V Gress, M Roussy, L Boulianne, M Bilodeau, S Cardin, N El-Hachem, ... Blood Advances, bloodadvances. 2022008899, 2023 | 4 | 2023 |
Coordination of Pro-and Anti-Inflammatory Signals Determine Human Hematopoietic Stem and Progenitor Cell Expansion J Chagraoui, E Tomellini, L Aubert, I Fares, JF Spinella, S Girard, ... Blood 132, 2555, 2018 | 2 | 2018 |
Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors L Aubert, E Bastien, O Renoult, C Guilbaud, K Özkan, D Brusa, C Bouzin, ... EMBO reports, 1-21, 2024 | 1 | 2024 |
Combined use of a trka inhibitor and an epha2 inhibitor for using in the treatment of solid cancers, and method for the prognosis of survival of a patient who has a solid cancer R Toillon, X Le Bourhis, C Corbet, L Aubert, M Guilbert US Patent App. 15/511,739, 2017 | 1 | 2017 |
Tumor acidosis-induced DNA damage response and tetraploidy: implications for ATM and ATR inhibitors. L Aubert, E Bastien, O Renoult, C Guilbaud, K Özkan, D Brusa, C Bouzin, ... EMBO Reports, 2024 | | 2024 |
Deciphering the interplay between circadian clock and tumor metabolism to optimize anticancer chronotherapies L Aubert, K Özkan, C Guilbaud, P Bruno, S Srhir, O Feron BACR (Belgian Association for Cancer Research) Annual Meeting, 2023 | | 2023 |
Deciphering the interplay between circadian rhythms and metabolic preferences in colorectal cancer cells and 3D spheroids. L Aubert, K Özkan, S Srhir, P Bruno, C Guilbaud, O Feron Gordon Research Conference" Clocks Across the Phylogenetic Tree, from Single …, 2023 | | 2023 |